ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

Aspirin Use Associated With Lower Cancer Indicence, Death

April 27, 2007

Bristol-Myers Nominations Open

August 10, 1979

RFA For Patterns Of Care Studies Announced By DCCR

November 10, 1978

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

January 23, 2004